Bosh sahifaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Yopilish kursi
0,59 $
Kunlik diapazon
0,58 $ - 0,60 $
Yillik diapazon
0,36 $ - 9,08 $
Bozor kapitalizatsiyasi
3,35 mln USD
Oʻrtacha hajm
55,20 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,31 mln | 9,90% |
Joriy xarajat | 2,79 mln | 33,48% |
Sof foyda | -1,21 mln | 70,50% |
Sof foyda marjasi | -52,49 | 73,16% |
Har bir ulushga tushum | — | — |
EBITDA | -1,28 mln | -28,61% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 430,00 ming | -85,29% |
Jami aktivlari | 3,42 mln | -62,11% |
Jami passivlari | 3,55 mln | -37,90% |
Umumiy kapital | -129,00 ming | — |
Tarqatilgan aksiyalar | 5,82 mln | — |
Narxi/balansdagi bahosi | -19,50 | — |
Aktivlardan daromad | -88,29% | — |
Kapitaldan daromad | -166,24% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,21 mln | 70,50% |
Operatsiyalardan naqd pul | -972,00 ming | -19,12% |
Sarmoyadan naqd pul | 0,00 | 100,00% |
Moliyadan naqd pul | 500,00 ming | 2 023,08% |
Naqd pulning sof oʻzgarishi | -346,00 ming | -35,69% |
Boʻsh pul | -382,25 ming | -249,46% |
Haqida
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Tashkil etilgan
2000
Sayt
Xodimlar soni
14
